T2 Biosystems, Inc. (TTOO)

T2 Biosystems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.76	16.24	11.88	23.8	17.34	11.21
Short-Term Investments	0	0	0	10	25.4	0
Cash & Cash Equivalents	6.76	16.24	11.88	33.79	42.74	11.21
Cash Growth	-36.64%	36.70%	-64.84%	-20.94%	281.16%	-78.01%
Receivables	1.59	1.42	2.16	5.13	5.1	2.83
Inventory	4.67	4.82	4.29	3.91	3.64	3.6
Other Current Assets	2.54	2.71	1.03	1.56	2.11	1.26
Total Current Assets	15.56	25.19	19.36	44.39	53.58	18.9
Property, Plant & Equipment	8.64	9.05	13.27	14.44	14.81	9.21
Long-Term Investments	0	0	0	0	10	0
Other Long-Term Assets	0.55	0.56	1.69	1.7	0.69	0.39
Total Long-Term Assets	9.2	9.61	14.97	16.15	25.49	9.59
Total Assets	24.76	34.8	34.33	60.54	79.08	28.49
Accounts Payable	1.89	1.53	1.3	2.83	2.06	3.75
Deferred Revenue	0.28	0.31	0.22	0.55	0.65	0.33
Current Debt	43.32	42.9	1.35	1.17	0	42.9
Other Current Liabilities	10.78	11.42	7.26	7.14	7.09	13.59
Total Current Liabilities	56.26	56.15	10.13	11.69	9.8	60.57
Long-Term Debt	6.18	6.6	57.87	57.15	55.77	1.87
Other Long-Term Liabilities	0.09	0.08	5.99	4.61	4.78	0.05
Total Long-Term Liabilities	6.27	6.68	63.85	61.75	60.55	1.92
Total Liabilities	62.53	62.83	73.98	73.44	70.35	62.49
Total Debt	49.5	49.5	59.22	58.32	55.77	44.78
Debt Growth	-16.61%	-16.41%	1.53%	4.58%	24.55%	5.67%
Retained Earnings	-597.83	-584.3	-534.22	-472.22	-422.98	-376.18
Comprehensive Income	0	0	0	-0	0.01	0
Shareholders' Equity	-37.77	-28.04	-39.66	-12.9	8.73	-34.01
Net Cash / Debt	-42.74	-33.26	-47.34	-24.53	-13.03	-33.56
Net Cash Per Share	-8.39	-12.74	-928.12	-772.09	-536.88	-3687.32
Working Capital	-40.7	-30.96	9.23	32.71	43.78	-41.68
Book Value Per Share	-7.41	-10.74	-777.50	-406.11	359.59	-3736.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).